Akimitsu Miyauchi - Publications

Effectiveness of romosozumab in patients with osteoporosis at high fracture risk: a Japanese real-world study.

Journal: Journal of bone and mineral metabolism

Published: June 29, 2023

Efficacy and safety of romosozumab among Japanese postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease.

Journal: Journal of bone and mineral metabolism

Published: November 04, 2021

Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: June 02, 2021

Romosozumab and antiresorptive treatment: the importance of treatment sequence.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: April 21, 2021

Romosozumab followed by denosumab in Japanese women with high fracture risk in the FRAME trial.

Journal: Journal of bone and mineral metabolism

Published: June 30, 2020

Correction to: Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial.

Journal: Journal of bone and mineral metabolism

Published: March 22, 2020

Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial.

Journal: Journal of bone and mineral metabolism

Published: May 16, 2019

Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension.

Journal: Archives of osteoporosis

Published: March 01, 2019

The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study.

Journal: JBMR plus

Published: December 10, 2018

One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: May 18, 2018

Correction to: Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review.

Journal: Archives of osteoporosis

Published: May 11, 2018

A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis.

Journal: The Journal of clinical endocrinology and metabolism

Published: September 29, 2017